Profile data is unavailable for this security.
About the company
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
- Revenue in USD (TTM)2.93bn
- Net income in USD685.60m
- Incorporated1923
- Employees10.07k
- LocationWest Pharmaceutical Services Inc530 Herman O. West DriveEXTON 19341United StatesUSA
- Phone+1 (630) 577-8800
- Fax+1 (800) 345-9800
- Websitehttps://www.westpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABIOMED, Inc. | 1.06bn | 217.58m | 12.81bn | 2.00k | 61.92 | 8.70 | 54.34 | 12.62 | 4.74 | 4.74 | 23.00 | 33.71 | 0.6681 | 2.19 | 11.75 | 527,367.40 | 13.76 | 16.91 | 14.96 | 18.75 | 81.48 | 82.13 | 20.60 | 23.45 | 6.86 | -- | 0.00 | 0.00 | 21.74 | 18.30 | -39.47 | 21.24 | -6.64 | -- |
| Cooper Companies Inc | 3.14bn | 948.00m | 16.07bn | 12.00k | 17.46 | 2.34 | 12.81 | 5.22 | 19.02 | 19.02 | 62.95 | 142.26 | 0.302 | 1.81 | 6.14 | 261,625.00 | 9.12 | 14.09 | 10.45 | 15.99 | 65.90 | 65.03 | 30.20 | 34.48 | 0.6882 | -- | 0.3168 | 0.3386 | 20.22 | 8.24 | 1,135.19 | 60.80 | 7.03 | 0.00 |
| Hologic, Inc. | 5.23bn | 1.51bn | 17.83bn | 6.71k | 12.16 | 3.61 | 9.23 | 3.45 | 5.94 | 5.94 | 20.54 | 20.03 | 0.5824 | 3.52 | 6.35 | 779,433.30 | 16.85 | 8.33 | 19.53 | 10.17 | 63.53 | 58.35 | 28.93 | 16.16 | 3.32 | 35.74 | 0.3627 | 0.00 | 49.14 | 14.74 | 67.82 | 41.42 | 10.56 | -- |
| Insulet Corporation | 1.18bn | 34.60m | 17.95bn | 2.30k | 550.92 | 43.12 | 191.56 | 15.46 | 0.4765 | 0.4765 | 16.74 | 6.09 | 0.5836 | 1.45 | 7.68 | 512,217.40 | 1.71 | 0.1989 | 1.95 | 0.2255 | 68.07 | 65.32 | 2.94 | 0.3174 | 3.54 | 2.48 | 0.7697 | 0.00 | 21.49 | 24.52 | 147.06 | -- | 40.87 | -- |
| Steris PLC | 4.77bn | 376.96m | 20.90bn | 16.42k | 56.21 | 3.28 | 21.37 | 4.41 | 3.74 | 3.74 | 47.37 | 64.02 | 0.4099 | 4.39 | 6.33 | 290,654.80 | 3.22 | 5.33 | 3.54 | 5.84 | 44.16 | 43.08 | 7.87 | 10.08 | 1.35 | 8.18 | 0.3183 | 39.11 | 47.55 | 11.90 | -38.63 | 17.27 | 10.71 | 9.17 |
| Align Technology, Inc. | 3.99bn | 619.03m | 21.37bn | 22.54k | 36.87 | 6.24 | 30.54 | 5.63 | 7.81 | 7.81 | 50.36 | 46.11 | 0.7121 | 4.47 | 4.59 | 177,008.70 | 11.05 | 25.12 | 16.07 | 36.50 | 72.60 | 73.40 | 15.52 | 30.36 | 1.15 | -- | 0.00 | 0.00 | 59.90 | 29.63 | -56.53 | 32.41 | 41.55 | -- |
| Zimmer Biomet Holdings Inc | 7.41bn | 299.60m | 23.60bn | 19.50k | 80.89 | 1.99 | 18.57 | 3.26 | 1.42 | 1.09 | 35.28 | 57.82 | 0.3243 | 0.9683 | 5.48 | 379,841.00 | 1.32 | 1.03 | 1.49 | 1.16 | 69.57 | 71.16 | 4.06 | 3.31 | 0.9499 | 7.03 | 0.3319 | 77.35 | 11.56 | 0.4339 | 400.00 | 7.13 | -1.88 | 0.00 |
| West Pharmaceutical Services Inc. | 2.93bn | 685.60m | 24.40bn | 10.07k | 37.72 | 10.34 | 31.74 | 8.57 | 8.98 | 8.98 | 38.33 | 32.76 | 0.9304 | 4.58 | 5.81 | 290,968.70 | 21.17 | 14.11 | 25.35 | 16.78 | 40.87 | 35.61 | 22.75 | 16.01 | 2.41 | 128.80 | 0.0942 | 13.61 | 31.89 | 13.41 | 90.76 | 35.68 | 8.29 | 7.09 |
| Baxter International Inc | 14.19bn | 1.01bn | 29.69bn | 60.00k | 30.01 | 3.41 | 13.66 | 2.13 | 2.00 | 2.00 | 27.99 | 17.58 | 0.551 | 3.65 | 6.32 | 236,550.00 | 3.97 | 6.03 | 4.63 | 7.22 | 39.16 | 41.58 | 7.20 | 10.02 | 1.33 | 8.00 | 0.6521 | 38.31 | 9.52 | 4.70 | 16.52 | -23.70 | 0.6589 | 16.53 |
| DexCom, Inc. | 2.67bn | 199.70m | 33.42bn | 6.30k | 189.28 | 15.62 | 104.31 | 13.18 | 0.4741 | 0.4741 | 6.52 | 5.75 | 0.55 | 2.67 | 5.12 | 424,349.20 | 4.11 | 5.56 | 4.80 | 6.50 | 67.15 | 67.29 | 7.47 | 8.91 | 4.30 | 5.49 | 0.4735 | 0.00 | 27.08 | 33.69 | -68.66 | -- | 47.52 | -- |
| ResMed Inc. | 3.54bn | 779.48m | 34.64bn | 7.97k | 45.90 | 10.87 | 37.84 | 10.07 | 5.31 | 5.31 | 24.10 | 22.42 | 0.7459 | 2.69 | 6.60 | 444,101.90 | 16.43 | 11.98 | 19.62 | 14.03 | 56.29 | 57.66 | 22.02 | 17.49 | 1.56 | 33.08 | 0.1719 | 45.57 | 8.11 | 11.70 | -23.67 | 6.13 | 11.49 | 5.39 |
Data as of Aug 11 2022. Currency figures normalised to West Pharmaceutical Services Inc's reporting currency: US Dollar USD
46.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2022 | 8.42m | 11.36% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2022 | 6.38m | 8.61% |
| BlackRock Fund Advisorsas of 31 Mar 2022 | 4.59m | 6.19% |
| SSgA Funds Management, Inc.as of 31 Mar 2022 | 3.39m | 4.58% |
| Franklin Advisers, Inc.as of 31 Mar 2022 | 2.76m | 3.72% |
| APG Asset Management NVas of 31 Mar 2022 | 2.54m | 3.43% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2022 | 1.77m | 2.39% |
| WCM Investment Management LLCas of 31 Mar 2022 | 1.53m | 2.06% |
| Geode Capital Management LLCas of 31 Mar 2022 | 1.43m | 1.93% |
| BlackRock Advisors LLCas of 31 Mar 2022 | 1.28m | 1.72% |
More ▼
Data from 31 Mar 2022 - 31 Mar 2022Source: FactSet Research Systems Inc.
